Skip to content

Clinical trials

Lung Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Belgium Clear all

143 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20022
20034
20043
20051
20067
20074
20094
20104
20117
20124
20135
20143
201512
20165
20177
20182
20197
20205
20217
20229
20235
202411
202510
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Recruiting26
Unknown status17
Terminated15
Active, not recruiting13
Withdrawn4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC14
AstraZeneca10
Novartis Pharmaceuticals10
Bristol-Myers Squibb6
Eli Lilly and Company6
Hasselt University6
Amgen5
Hoffmann-La Roche5
KU Leuven4
Universitair Ziekenhuis Brussel4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms143
Carcinoma, Non-Small-Cell Lung73
Neoplasms19
Breast Neoplasms15
Colorectal Neoplasms13
Adenocarcinoma of Lung11
Lung Diseases11
Neoplasm Metastasis11
Head and Neck Neoplasms9
Ovarian Neoplasms9

Trials

Showing 76 to 100 of 143. Each trial links to its page on Pharma Observatory.

43 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.